Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$248K	Hold	568	–	–	0.11%	57
2023 Q2	$299K	Hold	568	–	–	0.13%	51
2023 Q1	$272K	Hold	568	–	–	0.13%	53
2022 Q4	$232K	Buy	+568	New	+$220K	0.12%	57
2022 Q2	–	Sell	-568	Closed	-$311K	–	62
2022 Q1	$311K	Hold	568	–	–	0.11%	52
2021 Q4	$374K	Hold	568	–	–	0.13%	48
2021 Q3	$349K	Hold	568	–	–	0.14%	49
2021 Q2	$395K	Hold	568	–	–	0.14%	45
2021 Q1	$302K	Hold	568	–	–	0.12%	55
2020 Q4	$284K	Hold	568	–	–	0.13%	60
2020 Q3	$224K	Buy	+568	New	+$210K	0.1%	63

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wealth Advisors's IDXX Position: Q3 2023 in Review

Wealth Advisors held its Idexx Laboratories (IDXX) position steady in Q3 2023 at 568 shares worth $248K. The position accounts for 0.11% of the portfolio, ranked #57.

Wealth Advisors first reported a position in IDXX in Q3 2020 and has held it in 11 quarters since. The position peaked at $395K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

Wealth Advisors held 568 shares of Idexx Laboratories worth $248K as of Q3 2023.
Wealth Advisors left its Idexx Laboratories share count unchanged in Q3 2023.
Idexx Laboratories made up 0.11% of Wealth Advisors's portfolio in Q3 2023, its #57 holding.
Wealth Advisors first reported a position in Idexx Laboratories in Q3 2020 and has held it in 11 quarters since.
Wealth Advisors's Idexx Laboratories position peaked at $395K in Q2 2021.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Wealth Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.